In the last three months, 9 analysts shared their views on Globe Life GLand reveal different outlooks from optimistic to pessimistic.
The table below provides a summary of their recent ratings, showing the changes in sentiment over the past 30 days and comparing them to previous months.
Bullish | Somewhat optimistic | Indifferent | A bit bearish | Bearish | |
---|---|---|---|---|---|
Overall Ratings | 0 | 4 | 5 | 0 | 0 |
Last 30 days | 0 | 0 | 1 | 0 | 0 |
1M ago | 0 | 3 | 1 | 0 | 0 |
2 months ago | 0 | 1 | 3 | 0 | 0 |
3 months ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets analyzed by analysts provide insights with an average target of $94.33, a high estimate of $118.00, and a low estimate of $65.00. This current average is up 5.33% from the previous average price target of $89.56.
Interpreting analyst ratings: A closer look
Globe Life’s standing among financial professionals is evident by an in-depth study of analysts’ recent activities. The following summary provides an overview of the key analysts, their recent reviews, and any adjustments to their ratings and price targets.
analyst | Analyst firm | Action taken | Reviews | Current price target | Previous price target |
---|---|---|---|---|---|
Nigel Dally | Morgan Stanley | Increases | balance | 83,00 € | 66,00 € |
Ryan Krueger | Keefe, Bruyette and Woods | Increases | Exceed | 118,00 € | 110.00 USD |
John Barnidge | Piper Sandler | Increases | Obesity | 106,00 € | 105,00 € |
Mark Hughes | Trust securities | Increases | Hold | 90,00 € | $80.00 |
Elyse Greenspan | Wells Fargo | Increases | Obesity | 108,00 € | 105,00 € |
Nigel Dally | Morgan Stanley | Increases | balance | 65,00 € | 62,00 € |
Suneet Kamath | Jefferies | Increases | Hold | 88,00 € | 85,00 € |
John Barnidge | Piper Sandler | Lowers | Obesity | 105,00 € | 110.00 USD |
Thomas Gallagher | Evercore ISI Group | Increases | In harmony | 86,00 € | 83,00 € |
Key findings:
- Action taken: Analysts react to changes in market conditions and company performance and update their recommendations frequently. Whether they maintain, increase or decrease their rating reflects their reaction to recent developments at Globe Life. This information provides a snapshot of how analysts perceive the current state of the company.
- Evaluation: Analysts provide qualitative ratings for stocks ranging from outperform to underperform. These ratings provide insight into expectations for Globe Life’s relative performance compared to the overall market.
- Price targets: Analysts understand forecasts and provide estimates for Globe Life’s future value. Examining current and past targets provides insight into analysts’ changing expectations.
Evaluating these analyst ratings along with key financial indicators can provide a comprehensive view of Globe Life’s market position. Stay informed and make informed decisions with the help of our ratings table.
Stay up to date with Globe Life analyst ratings.
Get to know Globe Life better
Globe Life Inc. is an insurance holding company. It offers a variety of life and supplemental health insurance products and annuities to a broad customer base. The Company’s core activities are organized into four reportable segments: Life Insurance, Supplemental Health Insurance, Annuities and Investments. The investment activities conducted by the Investment segment focus on seeking investments with a rate of return and duration appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, expected returns are considered in setting insurance premium rates and product profitability expectations.
Key indicators: Globe Life’s financial health
Market capitalization analysis: The company has a lower market capitalization profile, which is below the industry average, indicating a smaller size compared to peers.
Positive sales trend: Looking at Globe Life’s financial figures over 3 months shows a positive development. The company achieved a remarkable sales growth rate of 8.58% as of June 30, 2024 and shows a significant increase in revenue. Compared to its competitors, the company has struggled and its growth rate has been below the average of its competitors in the financial sector.
Net margin: Globe Life’s net margin exceeds industry standards and underlines the company’s exceptional financial performance. With an impressive 17.94% The net margin enables the company to manage costs effectively and achieve high profitability.
Return on equity (ROE): Globe Life’s return on equity exceeds industry averages and reaches 5.03%This stands for sound financial management and efficient use of equity.
Return on assets (ROA): Globe Life’s ROA exceeds industry standards and underlines the company’s exceptional financial performance. With an impressive 0.91% ROA: The company uses its assets effectively to generate optimal returns.
Debt management: With a below-average debt level of 0.44Globe Life follows a prudent financial strategy and takes a balanced approach to debt management.
The importance of analyst ratings explained
Analysts work in banking and finance and typically specialize in reporting on stocks or specific sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish “analyst ratings” on stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts expand their insights by providing forecasts for key metrics such as earnings, revenue and growth estimates. This supplementary information provides further guidance to traders. It is important to recognize that despite their specialization, analysts are also human and can only make forecasts based on their beliefs.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market news and data provided by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.